Kevin Tang - 29 May 2026 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 21:54:36 UTC
Prior SEC filing
03 Mar 2026
Next SEC filing
29 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Kevin Tang

Key filing fact

Kevin Tang filed Form 4 for Aurinia Pharmaceuticals Inc. (AUPH) on 02 Jun 2026.

Key facts

  • This page summarizes Kevin Tang's Form 4 filing for Aurinia Pharmaceuticals Inc. (AUPH).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 21:54.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: +$12,455,227.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001178579 Primary reporting owner

TANG KEVIN

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
4747 EXECUTIVE DR, SUITE 210, SAN DIEGO
Signature
Kevin Tang
Signature date
02 Jun 2026
CIK 0001232621

TANG CAPITAL MANAGEMENT LLC

Relationship
10%+ Owner
Address
4747 EXECUTIVE DR, SUITE 210, SAN DIEGO
Signature
Kevin Tang, Manager
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUPH transaction

Common Shares

Purchase

Transaction value
$35,290
Shares
+2,299
Change %
+0.02%
Price
$15.35
Shares after
12,231,799
Date
29 May 2026
Ownership
By LP
Footnotes
F1, F2
AUPH transaction

Common Shares

Purchase

Transaction value
$35,290
Shares
+2,299
Change %
+0.02%
Price
$15.35
Shares after
12,231,799
Date
29 May 2026
Ownership
By LP
Footnotes
F1, F2
AUPH transaction

Common Shares

Purchase

Transaction value
$4,021,661
Shares
+262,682
Change %
+2.1%
Price
$15.31
Shares after
12,494,481
Date
29 May 2026
Ownership
By LP
Footnotes
F2, F3
AUPH transaction

Common Shares

Purchase

Transaction value
$4,021,661
Shares
+262,682
Change %
+2.1%
Price
$15.31
Shares after
12,494,481
Date
29 May 2026
Ownership
By LP
Footnotes
F2, F3
AUPH transaction

Common Shares

Purchase

Transaction value
$5,249,001
Shares
+343,521
Change %
+2.7%
Price
$15.28
Shares after
12,838,002
Date
01 Jun 2026
Ownership
By LP
Footnotes
F2, F4
AUPH transaction

Common Shares

Purchase

Transaction value
$5,249,001
Shares
+343,521
Change %
+2.7%
Price
$15.28
Shares after
12,838,002
Date
01 Jun 2026
Ownership
By LP
Footnotes
F2, F4
AUPH transaction

Common Shares

Purchase

Transaction value
$1,519
Shares
+99
Change %
+0%
Price
$15.34
Shares after
12,838,101
Date
01 Jun 2026
Ownership
By LP
Footnotes
F2, F5
AUPH transaction

Common Shares

Purchase

Transaction value
$1,519
Shares
+99
Change %
+0%
Price
$15.34
Shares after
12,838,101
Date
01 Jun 2026
Ownership
By LP
Footnotes
F2, F5
AUPH transaction

Common Shares

Purchase

Transaction value
$3,147,756
Shares
+206,005
Change %
+1.6%
Price
$15.28
Shares after
13,044,106
Date
02 Jun 2026
Ownership
By LP
Footnotes
F2, F6
AUPH transaction

Common Shares

Purchase

Transaction value
$3,147,756
Shares
+206,005
Change %
+1.6%
Price
$15.28
Shares after
13,044,106
Date
02 Jun 2026
Ownership
By LP
Footnotes
F2, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AUPH transaction Derivative

Short Put Options (potential obligation to buy)

Other

Transaction value
Shares
+10,000
Change %
Price
$1.65*
Shares after
10,000
Date
02 Jun 2026
Ownership
By LP
Underlying class
Common Shares
Underlying amount
1,000,000
Exercise price
$15.00
Footnotes
F7, F8
AUPH transaction Derivative

Short Put Options (potential obligation to buy)

Other

Transaction value
Shares
+10,000
Change %
Price
$1.65*
Shares after
10,000
Date
02 Jun 2026
Ownership
By LP
Underlying class
Common Shares
Underlying amount
1,000,000
Exercise price
$15.00
Footnotes
F7, F8
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $15.33 to $15.38. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 6.

Footnote F2

Tang Capital Partners, LP ("TCP") beneficially owns 7,205,442 shares, Tang Capital Partners International, LP ("TCPI") beneficially owns 5,239,039 shares, Tang Capital Partners III, Inc. ("TCP III") beneficially owns 324,814 shares, and Tang Capital Partners IV, Inc. ("TCP IV") beneficially owns 274,811 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Kevin Tang is the sole director and Chief Executive Officer of TCP III and TCP IV, which are indirectly wholly owned by TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP, TCPI, TCP III and TCP IV (collectively, the "Funds").

Footnote F3

These shares were purchased in multiple transactions ranging from $15.05 to $15.37.

Footnote F4

These shares were purchased in multiple transactions ranging from $14.97 to $15.50.

Footnote F5

These shares were purchased at $15.34.

Footnote F6

These shares were purchased in multiple transactions ranging from $15.00 to $15.40.

Footnote F7

Each put option is exercisable only at the option of the counterparty through the expiration date of the put option.

Footnote F8

Securities are beneficially held by TCP III and TCP IV. The Funds sold 10,000 put options on June 2, 2026. Pursuant to the put option contracts, the Funds have the potential obligation to acquire 1,000,000 common shares of the Issuer at $15 expiring on January 15, 2027.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .